Back to News & Events

Medisafe Finalist in Reuters Pharma Awards

Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this prestigious award.

The final winners are set to be announced on December 1, 2022, in Philadelphia.

You may also like

PDURS: 7 Experts to Follow As the Draft FDA Guidelines Progress

Want to keep current on the FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS)? Follow the LinkedIn profiles 

..Read More

PDURS: What Four Top Law Firms Are Saying

The FDA’s draft guidelines for Prescription Drug Use Related Software (PDURS) have drawn significant attention from the legal community. Law 

..Read More

PDURS: How 7 Companies and Groups Responded to the Draft Guidelines

The FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS) have sparked considerable discussion among various stakeholders, including pharmaceutical 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us